Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(396)
Jonathan S. Serody
15
Patrick J. Stiff
9
David A. Gabriel
9
Dominic T. Moore
7
Don A. Gabriel
6
Journals
(22)
BIOL BLOOD MARROW TRANSPLANT
19
BONE MARROW TRANSPLANT
4
CANCER CHEMOTHER PHARMACOL
3
Transfusion
3
Blood
2
Keywords
(163)
Embed
Subscribe
Academic
Authors
Thomas C. Shea
Thomas C. Shea,University of North Carolina Chapel Hill,Oncology,Pharmacology,Physiology
Edit
Thomas C. Shea
University of North Carolina Chapel Hill
Publications:
64
|
Citations:
1666
Fields:
Oncology
,
Pharmacology
,
Physiology
View FAQ about top research areas and Fields of study
Collaborated with
396 co-authors
from 1987 to 2011
|
Cited by
5695 authors
Cumulative
Annual
Sort by:
Publications
(64)
BibTeX
|
RIS
|
RefWorks
Download
Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901
(
Citations: 1
)
Thomas Shea
,
Jeffrey Johnson
,
Peter Westervelt
,
Sherif Farag
,
John McCarty
,
Asad Bashey
,
Luis Isola
,
Lee-Anne Baxter-Lowe
,
Michael Kelly
,
Kouros Owzar
,
Charles Linker
Journal:
Biology of Blood and Marrow Transplantation - BIOL BLOOD MARROW TRANSPLANT
, vol. 17, no. 9, pp. 1395-1403, 2011
Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002)
Asad Bashey
,
Kouros Owzar
,
Jeffrey L. Johnson
,
Peggy S. Edwards
,
Michael Kelly
,
Lee-Ann Baxter-Lowe
,
Steven Devine
,
Sherif Farag
,
David Hurd
,
Edward Ball
,
Philip McCarthy
,
John Lister
Thomas C. Shea
http://academic.research.microsoft.com/io.ashx?type=5&id=30684412&selfId1=34483296&selfId2=0&maxNumber=12&query=
Journal:
Biology of Blood and Marrow Transplantation - BIOL BLOOD MARROW TRANSPLANT
, vol. 17, no. 4, pp. 558-565, 2011
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients under age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808
(
Citations: 3
)
J. E. Kolitz
,
S. L. George
,
G. Marcucci
,
R. Vij
,
B. L. Powell
,
S. L. Allen
,
D. J. DeAngelo
,
T. C. Shea
,
W. Stock
,
M. R. Baer
,
V. Hars
,
K. Maharry
http://academic.research.microsoft.com/io.ashx?type=5&id=29978378&selfId1=34483296&selfId2=0&maxNumber=12&query=
Journal:
Blood
, vol. 115, no. 23, 2010
Genetic Tests To Evaluate Prognosis and Predict Therapeutic Response in Acute Myeloid Leukemia
(
Citations: 2
)
Margaret L. Gulley
,
Thomas C. Shea
,
Yuri Fedoriw
Journal:
Journal of Molecular Diagnostics - J MOL DIAGN
, vol. 12, no. 1, pp. 3-16, 2010
A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR
(
Citations: 1
)
Hillard M. Lazarus
,
Mei-Jie Zhang
,
Jeanette Carreras
,
Brandon M. Hayes-Lattin
,
Asli Selmin Ataergin
,
Jacob D. Bitran
,
Brian J. Bolwell
,
César O. Freytes
,
Robert Peter Gale
,
Steven C. Goldstein
,
Gregory A. Hale
,
David J. Inwards
Thomas C. Shea
http://academic.research.microsoft.com/io.ashx?type=5&id=30667862&selfId1=34483296&selfId2=0&maxNumber=12&query=
Journal:
Biology of Blood and Marrow Transplantation - BIOL BLOOD MARROW TRANSPLANT
, vol. 16, no. 1, pp. 35-45, 2010
Sort by:
Citations
(1666 times by 1441 publications)
Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
A Olivieri
,
M Marchetti
,
R Lemoli
,
C Tarella
,
A Iacone
,
F Lanza
,
A Rambaldi
,
A Bosi
Journal:
Bone Marrow Transplantation - BONE MARROW TRANSPLANT
, vol. 47, no. 3, pp. 342-351, 2012
A Novel SolidPhase Site-Specific PEGylation Enhances the In Vitro and In Vivo Biostabilty of Recombinant Human Keratinocyte Growth Factor 1
Zhifeng Huang
,
Guanghui Zhu
,
Chuanchuan Sun
,
Jingui Zhang
,
Yi Zhang
,
Youting Zhang
,
Chaohui Ye
,
Xiaojie Wang
,
Dariush Ilghari
,
Xiaokun Li
Journal:
PLOS One
, vol. 7, no. 5, 2012
Fibroblast Growth Factor 22 Is Not Essential for Skin Development and Repair but Plays a Role in Tumorigenesis
Monika Jarosz
,
Luisa Robbez-Masson
,
Athina-Myrto Chioni
,
Barbara Cross
,
Ian Rosewell
,
Richard Grose
Journal:
PLOS One
, vol. 7, no. 6, 2012
Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma
D G Stover
,
V K Reddy
,
Y Shyr
,
B N Savani
,
N Reddy
Journal:
Bone Marrow Transplantation - BONE MARROW TRANSPLANT
, vol. 47, no. 1, pp. 82-87, 2012
Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects
(
Citations: 4
)
Su Lu
,
Zhanwei Wang
,
Dan Cui
,
Hong Liu
,
Xishan Hao
Journal:
Breast Cancer Research and Treatment - BREAST CANCER RES TREAT
, vol. 125, no. 1, pp. 253-259, 2011
Comments